These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19339839)
1. HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient. Ross CL; Hunt BJ; Wyncoll D; Hodgkiss A; Peters B Blood Coagul Fibrinolysis; 2009 Mar; 20(2):157-60. PubMed ID: 19339839 [TBL] [Abstract][Full Text] [Related]
2. Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases. Evans MW; Vaughan LB; Giffi VS; Zimrin AB; Hess JR AIDS Patient Care STDS; 2010 Jun; 24(6):349-52. PubMed ID: 20515417 [TBL] [Abstract][Full Text] [Related]
3. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection. Mak SK; Lo KY; Lo MW; Chan SF; Lo KC; Wong YY; Tong GM; Wong PN; Ma ES; Wong AK Hong Kong Med J; 2009 Jun; 15(3):201-8. PubMed ID: 19494376 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura. Benetatos L; Vassou A; Bourantas KL Clin Lab Haematol; 2006 Aug; 28(4):288-9. PubMed ID: 16898975 [No Abstract] [Full Text] [Related]
5. A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke. Ozdogu H; Boga C; Kizilkilic E; Yeral M; Kozanoglu I; Karatas M J Thromb Thrombolysis; 2007 Apr; 23(2):147-50. PubMed ID: 17221322 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab. Onitilo AA; Engel JM; Clouse LH; Gerndt KM J Vasc Interv Radiol; 2009 Feb; 20(2):275-6. PubMed ID: 19054690 [No Abstract] [Full Text] [Related]
7. Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Limal N; Cacoub P; Sène D; Guichard I; Piette JC Lupus; 2008 Jan; 17(1):69-71. PubMed ID: 18089688 [No Abstract] [Full Text] [Related]
8. Rituximab for thrombotic thrombocytopenic purpura. Kivity S; Agmon-Levin N Isr Med Assoc J; 2011 Jul; 13(7):436-7. PubMed ID: 21838188 [No Abstract] [Full Text] [Related]
9. [Case report; successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura]. Yoshii Y; Matsumura Y; Boku S; Kamitsuji Y; Yasuda T; Kawase Y; Matsumoto M; Fujimura Y; Uoshima N Nihon Naika Gakkai Zasshi; 2013 Jan; 102(1):147-9. PubMed ID: 23777126 [No Abstract] [Full Text] [Related]
10. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P; Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591 [TBL] [Abstract][Full Text] [Related]
13. Successful use of rituximab in a patient with refractory thrombotic thrombocytopaenic purpura complicated by polymyositis. Takada H; Hosoya T; Kimura N; Kawahata K; Kohsaka H Scand J Rheumatol; 2017 Mar; 46(2):163-165. PubMed ID: 27309121 [No Abstract] [Full Text] [Related]
14. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292 [TBL] [Abstract][Full Text] [Related]
15. Spotlight on rituximab as a new therapeutic option for dermatomyositis and thrombotic thrombocytopenic purpura. Ferrer E; Moral MA Drug News Perspect; 2006 Oct; 19(8):482-4. PubMed ID: 17160148 [TBL] [Abstract][Full Text] [Related]
16. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab. Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381 [TBL] [Abstract][Full Text] [Related]
17. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies. Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804 [TBL] [Abstract][Full Text] [Related]
18. Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease. Niewold TB; Alpert D; Scanzello CR; Paget SA J Rheumatol; 2006 Jun; 33(6):1194-6. PubMed ID: 16755668 [TBL] [Abstract][Full Text] [Related]
19. Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab. Herbei L; Venugopal P Clin Adv Hematol Oncol; 2006 Mar; 4(3):215-7; discussion 217-8. PubMed ID: 16728931 [No Abstract] [Full Text] [Related]
20. Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Scully M; Starke R; Lee R; Mackie I; Machin S; Cohen H Blood Coagul Fibrinolysis; 2006 Sep; 17(6):459-63. PubMed ID: 16905949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]